C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:C-TRI Co Ltd (047920) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9391
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C-TRI Co Ltd (C-TRI), a subsidiary of DAE HWA Pharmaceutical Co Ltd, is a pharmaceutical company that offers development of new peptide drugs. The company’s products include ethicals, over-the-counter drugs, Quasi-drugs, cosmetics, amendments, pharmaceuticals, taltirelin, desmopressin, prescription drugs, biodrugs and peptide therapeutics, among others. It also provides new innovative drugs, unnatural amino acids, peptide drugs, ionic liquids, peptide cosmetics, biopharmaceuticals, piroxicam gel, gynobetadine vaginal suppository, tablets, creams, lotions, gels and central nervous system drugs, among others. C-TRI offers services such as development of medicinal products, in-house production, contract manufacturing, research and development services, among others. The company provides its products and services to pharmaceutical and medicinal industries. C-TRI is headquartered in Namyangju, South Korea.

C-TRI Co Ltd (047920) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-TRI Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
DelSiTech and C-Tri Enter into Agreement 10
Debt Offering 11
Chem Tech Research Raises USD8.8 Million in Private Placement of Bonds Due 2019 11
Chem Tech Research Raises USD4.4 Million in Private Placement of Convertible Bonds Due 2019 12
C-TRI Co Ltd – Key Competitors 13
C-TRI Co Ltd – Key Employees 14
C-TRI Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-TRI Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-TRI Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
DelSiTech and C-Tri Enter into Agreement 10
Chem Tech Research Raises USD8.8 Million in Private Placement of Bonds Due 2019 11
Chem Tech Research Raises USD4.4 Million in Private Placement of Convertible Bonds Due 2019 12
C-TRI Co Ltd, Key Competitors 13
C-TRI Co Ltd, Key Employees 14
C-TRI Co Ltd, Other Locations 15

List of Figures
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
C-TRI Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[C-TRI Co Ltd (047920):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interface Inc:企業の戦略・SWOT・財務情報
    Interface Inc - Strategy, SWOT and Corporate Finance Report Summary Interface Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • ENN Energy Holdings Ltd (2688):石油・ガス:M&Aディール及び事業提携情報
    Summary ENN Energy Holdings Ltd (ENN) is a clean energy distributor that offers sales and distribution of piped gas, LNG and other energy products. The company conducts investment, operation and management of gas pipeline infrastructure, wholesale of gas, the sales, distribution of piped gas and oth …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoim …
  • Kukje Pharmaceutical Industry Co Ltd (002720):企業の財務・戦略的SWOT分析
    Summary Kukje Pharmaceutical Industry Co Ltd (Kukje) is a manufacturer, and distributor of pharmaceuticals, cosmetics and healthcare products. The company’s products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, other antibiotics, antifungal and antiviral agents. Kukj …
  • Sagent Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Sagent Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sagent Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Jordan Phosphate Mines Co. Plc.:企業の戦略・SWOT・財務情報
    Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report Summary Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hasbro, Inc. (HAS):企業の財務・戦略的SWOT分析
    Hasbro, Inc. (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bird Rock Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bird Rock Bio Inc (Bird Rock Bio), formerly RuiYi Inc is a clinical stage biopharmaceutical company that develops immuno-inflammatory regulators. The company’s products under development include RYI-018 is a peripheral antagonist antibody to cannabinoid receptor 1 intended for the treatment …
  • Elcam Medical:企業の製品パイプライン分析2018
    Summary Elcam Medical (Elcam) is a medical device company that produces disposable medical devices and components for the OEM market, and provides novel solutions for specialized flow control needs. The company offers products, which are used in the areas of intensive care medicine, anesthesia, infe …
  • Contact Energy Ltd (CEN):電力:M&Aディール及び事業提携情報
    Summary Contact Energy Ltd (Contact Energy) is an energy company that generates electricity and sells electricity, natural gas and liquefied petroleum gas to customers. It generates electricity from various sources of energy including thermal, hydro and geothermal sources of energy. It supplies elec …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Borges International Group SLU:企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • NGM Biopharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical stage biopharmaceutical company which focuses on the development of drug discovery platform to generate biologic drug candidates to treat cardio-metabolic, immuno-oncology and liver diseases. Its product pipeline includes NGM282, NGM386, NGM …
  • McCarthy Building Companies Inc:企業の戦略的SWOT分析
    McCarthy Building Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Jacobs Engineering Group Inc (JEC):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Entergy Corporation (ETR):電力:M&Aディール及び事業提携情報
    Summary Entergy Corporation (Entergy) is an integrated energy company that generates, transmits, distributes and sells electricity. The company generates electricity from various sources including natural gas, nuclear, coal, hydroelectric, solar and oil based power plants. Entergy also operates natu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆